project id: TCGA-SKCM; case submitter id: TCGA-GN-A26D; source center: 23; state: released; a260 a280 ratio: 1.84; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.9; rna integrity number: 9.8; age at index: 72; days to birth: -26494; days to death: 1460; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1936; age at diagnosis: 26494; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIC; ajcc pathologic t: T4b; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1204.0; icd 10 code: C44.5; last known disease status: not reported; morphology: 8720/3; primary diagnosis: Malignant melanoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Pelvic lymph nodes; synchronous malignancy: No; tissue or organ of origin: Skin, NOS; tumor grade: Not Reported; year of diagnosis: 2008; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 1093; days to sample procurement: 0; initial weight: 250.0; portion submitter id: TCGA-GN-A26D-06A-11; percent lymphocyte infiltration: 3.0; percent monocyte infiltration: 1.0; percent necrosis: 3.0; percent neutrophil infiltration: 1.0; percent normal cells: 0.0; percent stromal cells: 12.0; percent tumor cells: 85.0; percent tumor nuclei: 85.0;